Anke M. van Gestel

4.6k citations

24 papers · 3.7k indexed · 2 hit papers · h-index 17

Impact in

Rheumatology top 0.1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
Hematology top 0.5%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 23
- Rheumatoid Arthritis Research and Therapies 21
- Systemic Lupus Erythematosus Research 17
Hematology 7
- Autoimmune and Inflammatory Disorders Research 7

Co-authors: Piet L. C. M. van Riel M.L.L. Prevoo L.B.A. van de Putte M. H. van Rijswijk C.J. Haagsma Martin A. van't Hof Hilde Swinkels Paco M J Welsing
Journals: Lara D. Veeken (7 papers)Annals of the Rheumatic Diseases (2 papers)Best Practice & Research Clinical Rheumatology (1 paper)PharmacoEconomics (1 paper)Arthritis & Rheumatism (6 papers)
Partner nations: Netherlands Germany United States

In The Last Decade

Anke M. van Gestel

23 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

Validation of rheumatoid arthritis improvement criteria that include simplified joint counts 1998 · 635 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1998 Arthritis & Rheumatism
1996 Arthritis & Rheumatism

Peers

Countries citing papers authored by Anke M. van Gestel

Since Specialization

Citations

This map shows the geographic impact of Anke M. van Gestel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke M. van Gestel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke M. van Gestel more than expected).

Fields of papers citing papers by Anke M. van Gestel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke M. van Gestel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke M. van Gestel. The network helps show where Anke M. van Gestel may publish in the future.

Co-authors

The 25 scholars most cited alongside Anke M. van Gestel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anke M. van Gestel Line = papers co-authored together Anke M. van Gestel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Initial Validation of a Markov Model for the Economic Evaluation of (New) Treatments for Rheumatoid Arthritis PharmacoEconomics ·Paco M J Welsing, Johan L. Severens, Margriet Hartman, Anke M. van Gestel, Piet L. C. M. van Riel, Roland Laan	2006	21
2	The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: A longitudinal analysis Arthritis & Rheumatism ·Paco M J Welsing, Robert Landewé, Piet L. C. M. van Riel, Maarten Boers, Anke M. van Gestel, Sjef van der Linden, Hilde Swinkels, Désirée van der Heijde	2004	206
3	Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti‐TNF‐α Lara D. Veeken ·Alfons A den Broeder, M.C.W. Creemers, Anke M. van Gestel, Piet L. C. M. van Riel	2002	67
4	The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis Arthritis & Rheumatism ·Paco M J Welsing, Anke M. van Gestel, Hilde Swinkels, Lambertus A. Kiemeney, R. Chilton	2001	418
5	Health Assessment Questionnaire modifications: is standardisation needed? Annals of the Rheumatic Diseases ·Wang Cheng-dao, Paco M J Welsing, Anke M. van Gestel, Piet L. C. M. van Riel	2001	35
6	Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study. PubMed ·E. J. A. Kroot, Anke M. van Gestel, Hilde Swinkels, M. Albers, L B van de Putte, Zong-jie Wang	2001	40
7	ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. PubMed ·Anke M. van Gestel, Jennifer J. Anderson, Piet L. C. M. van Riel, Maarten Boers, C.J. Haagsma, Benjamin Rich, George A. Wells, M. Lange, David T. Felson	1999	213
8	Evaluation of established rheumatoid arthritis Best Practice & Research Clinical Rheumatology ·Anke M. van Gestel, Gerold Stucki	1999	15
9	Socio-economic consequences of rheumatoid arthritis in the first years of the disease. Lara D. Veeken ·Joachim Albers, Viktor Baradakov, P L van Riel, M.L.L. Prevoo, M.A. van ’t Hof, Anke M. van Gestel, Johan L. Severens	1999	134
10	Validation of rheumatoid arthritis improvement criteria that include simplified joint counts Arthritis & Rheumatism ·Anke M. van Gestel, C.J. Haagsma, Piet L. C. M. van Riel Hit paper breakdown →	1998	635
11	Early treatment of rheumatoid arthritis: rationale, evidence, and implications Annals of the Rheumatic Diseases ·L. B. A. van de Putte, Anke M. van Gestel, Piet L. C. M. van Riel	1998	24
12	Validation of rheumatoid arthritis improvement criteria that include simplified joint counts Arthritis & Rheumatism ·Anke M. van Gestel, C.J. Haagsma, Piet L. C. M. van Riel	1998	13
13	3 Evaluation of early rheumatoid arthritis disease activity and outcome Baillière s Clinical Rheumatology ·Anke M. van Gestel, Piet L. C. M. van Riel	1997	16
14	4 Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs) Baillière s Clinical Rheumatology ·Anke M. van Gestel, C.J. Haagsma, Daniel E. Fürst, Piet L. C. M. van Riel	1997	14
15	Development and Validation of Response Criteria in Rheumatoid Arthritis: Steps Towards an International Consensus on Prognostic Markers Lara D. Veeken ·Piet L. C. M. van Riel, Anke M. van Gestel, L. B. A. van de Putte	1996	97
16	Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteria Arthritis & Rheumatism ·Anke M. van Gestel, M.L.L. Prevoo, Martin A. van't Hof, M. H. van Rijswijk, L.B.A. van de Putte, Piet L. C. M. van Riel Hit paper breakdown →	1996	1268
17	ORAL STEROIDS AS BRIDGE THERAPY IN RHEUMATOID ARTHRITIS PATIENTS STARTING WITH PARENTERAL GOLD. A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL Lara D. Veeken ·Anke M. van Gestel, Roland Laan, C.J. Haagsma, L B van de Putte, P.L. van Riel	1995	66
18	REMISSION IN A PROSPECTIVE STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS. AMERICAN RHEUMATISM ASSOCIATION PRELIMINARY REMISSION CRITERIA IN RELATION TO THE DISEASE ACTIVITY SCORE Lara D. Veeken ·M.L.L. Prevoo, Anke M. van Gestel, Shuyuan Yan, M. H. van Rijswijk, L.B.A. van de Putte, Piet L. C. M. van Riel	1995	303
19	[The dairying veterinary approach to a high bulk milk cell count caused by Streptococcus agalactiae]. PubMed ·S.H. Loeffler, T.J.G.M. Lam, Herman W. Barkema, Karthik Thanneru, Ronald Lovaglio, Anke M. van Gestel	1995	5
20	Long-Term Usage and Side-Effect Profile of Sulphasalazine in Rheumatoid Arthritis Lara D. Veeken ·P. L. C. M. van Riel, Anke M. van Gestel, L. B. A. van de Putte	1995	8

About Anke M. van Gestel

Anke M. van Gestel is a scholar working on Rheumatology, Hematology, Pathology and Forensic Medicine, Pharmacology and Statistics, Probability and Uncertainty, having authored 24 papers that have together received 3.7k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (21 papers), Systemic Lupus Erythematosus Research (17 papers), Autoimmune and Inflammatory Disorders Research (7 papers), Lymphoma Diagnosis and Treatment (5 papers), Viral Infections and Immunology Research (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Reliability and Agreement in Measurement (1 paper). The work is most often cited by research in Rheumatology (3.3k citations), Hematology (1.3k citations), Genetics (579 citations), Pathology and Forensic Medicine (582 citations) and Immunology (605 citations). Anke M. van Gestel has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Piet L. C. M. van Riel, M.L.L. Prevoo, L.B.A. van de Putte, M. H. van Rijswijk, C.J. Haagsma, Martin A. van't Hof, Hilde Swinkels, Paco M J Welsing, Lambertus A. Kiemeney and L. B. A. van de Putte. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, Best Practice & Research Clinical Rheumatology, PharmacoEconomics and Arthritis & Rheumatism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact